Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines
India’s institutions now need to upgrade TTOs as strategic innovation units rather than administrative support cells
LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity
CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
18-year veteran Saharsh will position the CDMO as a premier global API process development and commercial manufacturing specialist
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
Expansion at the Oss (NL) site adds capacity and R&D capabilities, supporting the development and manufacturing of ADCs and other novel bioconjugates from First-in-Human to commercialization
Subscribe To Our Newsletter & Stay Updated
